Milind Javle
mjavle.bsky.social
Milind Javle
@mjavle.bsky.social
GI Oncologist, Dad, researcher, friend.
x.com
x.com
December 29, 2024 at 9:45 PM
MicroRNAs, Focus of Nobel Prize, Highlight Untapped Potential
December 29, 2024 at 6:01 PM
Discovery and Characterization of Brigimadlin, a Novel and Highly Potent MDM2–p53 Antagonist Suitable for Intermittent Dose Schedules
December 29, 2024 at 4:22 PM
How do plastics, including microplastics and plastic-associated chemicals, affect human health?
December 2, 2024 at 2:34 AM
Where do you stand?
(From Happiness equation, Neil Pasricha)
November 30, 2024 at 3:00 AM
Accelerated approvals: Early-phase success or premature authorization?
The pitfalls of accelerated approvals: failure rate of post-marketing confirmatory trials has increased from 13.8% duringthe 2007–2015 period to 33.3% during the 2016–2023 period.
November 30, 2024 at 2:38 AM
Caring for carers of people with cancer
November 25, 2024 at 10:24 AM
Patient Enrollment to Industry-Sponsored Versus Federally-Sponsored Cancer Clinical Trials.
Why federally funded trials are falling short of industry sponsored trials?
November 25, 2024 at 9:54 AM